Circularis Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$18.6M
- Investors
-
1
Circularis General Information
Description
Operator of a biotech company intended to regulate gene expression. The company offers gene therapy, biomanufacturing, and synthetic biology, improving the targeting of gene therapy and optimizing expression in poorly studied organisms, enabling medical practitioners to increase biotherapeutic production.
Contact Information
Website
www.circularisbiotech.comCorporate Office
- 2945 Webster Street
- Oakland, CA 94609
- United States
Corporate Office
- 2945 Webster Street
- Oakland, CA 94609
- United States
Circularis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 03-Oct-2022 | $18.6M | Completed | Out of Business | ||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Later Stage VC | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Seed Round | 09-Apr-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 04-Sep-2015 | $250K | Completed | Startup | ||
| 1. University Spin-Out | 01-Jan-2014 | Completed | Startup |
Circularis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 | ||||||||
| Seed |
Circularis Patents
Circularis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4433592-A1 | Compositions and methods for production of circular nucleic acid molecules | Inactive | 18-Nov-2021 | ||
| US-20250011767-A1 | Compositions and methods for production of circular nucleic acid molecules | Inactive | 18-Nov-2021 | ||
| WO-2023091704-A1 | Compositions and methods for production of circular nucleic acid molecules | Inactive | 18-Nov-2021 | C12N15/11 |
Circularis Signals
Circularis Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alix Ventures | Venture Capital | Minority | ||
| Bioverge | Venture Capital | Minority | ||
| California Life Sciences | Accelerator/Incubator | |||
| Cantos Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Circularis FAQs
-
When was Circularis founded?
Circularis was founded in 2014.
-
Where is Circularis headquartered?
Circularis is headquartered in Oakland, CA.
-
What is the size of Circularis?
Circularis has 9 total employees.
-
What industry is Circularis in?
Circularis’s primary industry is Discovery Tools (Healthcare).
-
Is Circularis a private or public company?
Circularis is a Private company.
-
What is the current valuation of Circularis?
The current valuation of Circularis is .
-
What is Circularis’s current revenue?
The current revenue for Circularis is .
-
How much funding has Circularis raised over time?
Circularis has raised $2.55M.
-
Who are Circularis’s investors?
Alix Ventures, Bioverge, California Life Sciences, Cantos Ventures, and are 5 of 8 investors who have invested in Circularis.
-
When was Circularis acquired?
Circularis was acquired on 03-Oct-2022.
-
Who acquired Circularis?
Circularis was acquired by Ginkgo Bioworks.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process